ClinicalTrials.gov
public full text
Public Domain
PECS Block: Plasma Bupivacaine Level
The purpose of this study is to determine peak plasma bupivacaine concentrations in a similar fashion for PECS I/II blocks. The investigators hypothesis is that the mean peak plasma levels for patients undergoing PECS I/II blocks will be less than the levels reported to cause early neurotoxicity of \[2.2 (0.9) micrograms/ml\]6 in patients receiving intravenous bupivacaine infusions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Radiofrequency, Perineural Injection, Idiopathic Carpal Tunnel Syndrome#887019
- Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block#1057209
- Correlation Between qNOX and Analgesia Nociception Index (ANI) Values During General Anesthesia#825799
- Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic#849599
- Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy#844264
Record · ID 1229328
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive